Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−16.83 M USD
0.00 USD
24.54 M
About OKYO Pharma Limited
Sector
Industry
CEO
Gary S. Jacob
Website
Headquarters
London
Founded
2007
ISIN
GG00BMFG5F62
FIGI
BBG015TS35V5
OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK geographical segments. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.